OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
141858

TongHwa Corp

Specialty ChemicalsVerified

TongHwa Corp's capital structure is highly leveraged, with a debt-to-equity ratio of 3.08, indicating significant reliance on long-term debt to fund operations. The company's liquidity position is weak, as evidenced by a current ratio of 0.45 and zero cash and equivalents, which aligns with the risk assessment flag of negative net cash after subtracting total debt. Profitability metrics are sharply negative, with a return on equity of -5.68% and a return on assets of -1.25%. These figures fall well below the typical performance benchmarks for the Specialty Chemicals industry, which usually expects positive returns in the 5-10% range for ROE and 2-5% for ROA. The company reported a net loss of 699.37 million TWD and an operating loss of 748.12 million TWD, reflecting a severe earnings contraction. The company's revenue is concentrated in domestic and overseas markets, including China, Thailand, Indonesia, Japan, and South Korea. However, the financial snapshot does not provide segment-specific revenue breakdowns, so it is unclear whether any single region or product line dominates the business. The lack of geographic diversification could expose the company to regional economic or regulatory risks. Growth trajectory is negative, with the company reporting a net loss and negative operating cash flow of 600.25 million TWD. The capital expenditure of 20.30 million TWD suggests minimal investment in growth, and the absence of positive revenue growth in the latest period indicates a challenging operating environment. Analysts have recorded a recent actual revenue of 2.32 billion TWD, which is lower than the 5.33 billion TWD in the financial snapshot, suggesting a possible reporting period mismatch or a decline in performance. Risk factors include liquidity constraints and a high debt load, with total liabilities of 43.64 billion TWD and total equity of 12.32 billion TWD. The risk assessment flags a medium liquidity risk and low dilution risk, but the negative net cash position and operating cash outflow of 600.25 million TWD suggest a potential need for refinancing or equity issuance in the near term. No dilution adjustments were applied in the valuation snapshot, but the company's current financial position could necessitate future capital raises. Recent events include a significant operating and net loss, with the company's last actual EPS at -10.17 TWD. The financial snapshot and analyst estimates indicate a deteriorating performance, with no clear signs of improvement in the near term. No recent filings or transcripts were provided to detail the causes of the losses or management's response.

30-day price · 1418-0.95 (-5.0%)
Low$17.50High$19.90Close$17.90As of22 May, 00:00 UTC
Profile
CompanyTongHwa Corp
Ticker1418.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. TongHwa Corp is a Taiwan-based manufacturer and seller of polyacrylonitrile fibers (acrylic cotton), primarily used in sweaters, flannel, blankets, carpets, and other textile products.

Classification. TongHwa Corp is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.

TongHwa Corp's capital structure is highly leveraged, with a debt-to-equity ratio of 3.08, indicating significant reliance on long-term debt to fund operations. The company's liquidity position is weak, as evidenced by a current ratio of 0.45 and zero cash and equivalents, which aligns with the risk assessment flag of negative net cash after subtracting total debt. Profitability metrics are sharply negative, with a return on equity of -5.68% and a return on assets of -1.25%. These figures fall well below the typical performance benchmarks for the Specialty Chemicals industry, which usually expects positive returns in the 5-10% range for ROE and 2-5% for ROA. The company reported a net loss of 699.37 million TWD and an operating loss of 748.12 million TWD, reflecting a severe earnings contraction. The company's revenue is concentrated in domestic and overseas markets, including China, Thailand, Indonesia, Japan, and South Korea. However, the financial snapshot does not provide segment-specific revenue breakdowns, so it is unclear whether any single region or product line dominates the business. The lack of geographic diversification could expose the company to regional economic or regulatory risks. Growth trajectory is negative, with the company reporting a net loss and negative operating cash flow of 600.25 million TWD. The capital expenditure of 20.30 million TWD suggests minimal investment in growth, and the absence of positive revenue growth in the latest period indicates a challenging operating environment. Analysts have recorded a recent actual revenue of 2.32 billion TWD, which is lower than the 5.33 billion TWD in the financial snapshot, suggesting a possible reporting period mismatch or a decline in performance. Risk factors include liquidity constraints and a high debt load, with total liabilities of 43.64 billion TWD and total equity of 12.32 billion TWD. The risk assessment flags a medium liquidity risk and low dilution risk, but the negative net cash position and operating cash outflow of 600.25 million TWD suggest a potential need for refinancing or equity issuance in the near term. No dilution adjustments were applied in the valuation snapshot, but the company's current financial position could necessitate future capital raises. Recent events include a significant operating and net loss, with the company's last actual EPS at -10.17 TWD. The financial snapshot and analyst estimates indicate a deteriorating performance, with no clear signs of improvement in the near term. No recent filings or transcripts were provided to detail the causes of the losses or management's response.
Key takeaways
  • TongHwa Corp is operating at a significant loss, with a net loss of 699.37 million TWD and a negative return on equity of -5.68%.
  • The company's capital structure is highly leveraged, with a debt-to-equity ratio of 3.08 and no cash reserves.
  • Profitability metrics are sharply negative, with ROA and ROE well below industry norms.
  • Revenue concentration in key markets like China and Southeast Asia may expose the company to regional economic risks.
  • The company's liquidity position is weak, with a current ratio of 0.45 and negative net cash after debt.
  • Analysts have recorded a recent actual revenue of 2.32 billion TWD, which is lower than the 5.33 billion TWD in the financial snapshot, suggesting a possible decline in performance.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$5.3M
Gross profit$4.1M
Operating income-$74.8M
Net income-$69.9M
R&D
SG&A
D&A
SBC
Operating cash flow-$600.2M
CapEx-$20.3M
Free cash flow-$83.5M
Total assets$5.60B
Total liabilities$4.36B
Total equity$1.23B
Cash & equivalents$0.00
Long-term debt$3.80B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.23B
Net cash-$3.80B
Current ratio0.5
Debt/Equity3.1
ROA-1.2%
ROE-5.7%
Cash conversion8.6%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1418Activity
Op margin-1403.9%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-1312.4%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin77.0%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-381.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity308.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Last actual EPS-10.17 TWD
Last actual revenue2,317,804,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 18:46 UTC#a7fdfee4
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 13:21 UTCJob: 36d43919